tricetamide
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Tyrosine-protein kinase JAK1INHIBITOR
JAK1 inhibitor
Prodrug of R-507
- Tyrosine-protein kinase JAK3INHIBITOR
JAK3 inhibitor
Prodrug of R-507
Chemistry & pharmacology
Loading structure…
SMILES
CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1- Mol. weight
- 324.38 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2106468 ↗
Also known as
- r-548
- r-548
- tricetamide
- tricetamide